International PhD Program in Biomedicine (m/f/d)

Doctoral researchers of this training program aim to gain critical new insights into the second messenger cyclic guanosine monophosphate (cGMP)’s role in cancer, cardiovascular diseases, and neurological disorders. cGMP is responsible for the transmission of signals in cells, and many drugs for the treatment of cardiovascular diseases target this signaling pathway. The latest findings suggest that cGMP-modulating drugs can be used even more widely. An important element of the GRK is its strong international dimension. Each student will be co-mentored by a principal investigator from another international institution (e.g. Harvard Medical School) who works on a related topic and she/he will visit the partner laboratory for a period of three months. Using state-of-the-art techniques including transgenic mouse and human cell models, advanced bio-imaging, and live-cell analyses, fellows will gain critical new insights into cGMP’s role in cancer, cardiovascular diseases, and neurological disorders.

We are looking for highly motivated graduates holding a Master's degree in the life sciences or similar.

The University of Tübingen seeks to increase the fraction of female scientists in research and teaching and particularly encourages applications from women. Disabled candidates are given preference if equally qualified.

We offer an exceptional research and educational environment:

• Multidisciplinary projects covering biochemistry, biophysics, cell signaling, neurobiology, pharmacology, physiology
• State-of-the-art technologies including transgenic mouse and human cell models, advanced bio-imaging, and live-cell analyses
• Structured qualification program with workshops, summer schools, soft skill courses, and conferences
• Strong international networking including three-month internships in Boston (e.g. at Harvard Medical School)

Application Deadline: March 1, 2025